New Risk • May 14
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 5.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 5.9% per year for the foreseeable future. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€63.0m market cap, or US$73.8m). Announcement • May 11
MHP Hotel AG, Annual General Meeting, Jun 19, 2026 MHP Hotel AG, Annual General Meeting, Jun 19, 2026, at 11:00 W. Europe Standard Time. New Risk • Jun 19
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 177% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€61.8m market cap, or US$70.9m). Reported Earnings • Jun 15
Full year 2024 earnings released Full year 2024 results: Revenue: €174.7m (up 28% from FY 2023). Net income: €1.42m (up €7.90m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Hospitality industry in Germany. Breakeven Date Change • Jun 10
Forecast breakeven date pushed back to 2025 The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule. Breakeven Date Change • May 08
Forecast breakeven date pushed back to 2025 The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule. Price Target Changed • Apr 23
Price target increased by 8.9% to €3.27 Up from €3.00, the current price target is an average from 3 analysts. New target price is 142% above last closing price of €1.35. Stock is up 19% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year. Price Target Changed • Mar 25
Price target increased by 13% to €3.40 Up from €3.00, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €1.30. Stock is up 6.6% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year. Price Target Changed • Feb 13
Price target increased by 13% to €3.40 Up from €3.00, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €1.40. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year. Price Target Changed • Oct 27
Price target decreased by 13% to €3.10 Down from €3.55, the current price target is an average from 3 analysts. New target price is 163% above last closing price of €1.18. Stock is down 7.8% over the past year. New Risk • Oct 19
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 39% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 39% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€49.9m market cap, or US$52.8m). New Risk • Oct 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€51.2m market cap, or US$53.8m). Price Target Changed • Apr 27
Price target increased to €3.54 Up from €3.00, the current price target is provided by 1 analyst. New target price is 121% above last closing price of €1.60. Stock is up 16% over the past year. Announcement • Jun 16
Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million. Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million on June 15, 2021. In return for the shares brought in, the current Munich Hotel Partners Gmbh shareholders are to receive a cash component of €6 million and a share component of 33.1 million new shares in Lifespot Capital AG in accordance with the contribution agreement. The share component is to be granted by way of a capital increase in kind, on which the general meeting of Lifespot Capital AG still has to decide. Kai-Steffen Scholz and Markus Ernst of Hengeler Mueller Partnerschaft von Rechtsanwälten mbB are acting as legal advisors to the shareholders of Munich Hotel Partners Gmbh. Is New 90 Day High Low • Jan 21
New 90-day high: €0.56 The company is up 270% from its price of €0.15 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 04
New 90-day high: €0.53 The company is up 250% from its price of €0.15 on 04 September 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period. Is New 90 Day High Low • Nov 05
New 90-day high: €0.25 The company is up 67% from its price of €0.15 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.